TSX plunges on sell-off amid political concerns... Inflation gathered pace in January... Husky could sell some of its Eastern Canadian assets...
The US specialty generics business of German pharmaceutical firm Boehringer Ingelheim is to be bought by Jordanian firm Hikma for $2.65 billion in cash and stock.
DuPont says that the strong dollar will hit its full-year earnings.
CNN Money’s “Fear and Greed” index shows that investors are currently extremely fearful of the market.
The trading week has started with a blow from the East as Chinese investors were spooked by weakness in the economy and opted to sell equities.
Technology has been responsible for many jobs in many sectors over the years but an announcement from one of Canada’s largest energy firms will send shockwaves through that sector, and others.
Albertan farmers are struggling with crops after a dry spring and some are considering the future for their livestock.
Tim Hortons and parent firm Restaurant Brands is reviewing its policies on the chain’s in-store digital screens known as Tims TV.
The week has started with drama as weak data and low commodity prices have prompted a sell-off of equities in Asia, led by China where the main Shanghai index fell 8 per cent.
Drug firm Allergan is to sell its generics unit to Teva Pharmaceutical Industries in a deal worth $40.5 billion.